loadpatents
name:-0.030009031295776
name:-0.026256084442139
name:-0.0061628818511963
LUO; Tianci Patent Filings

LUO; Tianci

Patent Applications and Registrations

Patent applications and USPTO patent grants for LUO; Tianci.The latest application filed is for "enveloped virus resistant to complement inactivation for the treatment of cancer".

Company Profile
8.24.29
  • LUO; Tianci - Fulton MD
  • Luo; Tianci - Clarksville MD
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Enveloped Virus Resistant to Complement Inactivation for the Treatment of Cancer
App 20220169701 - LUO; Tianci ;   et al.
2022-06-02
Enveloped virus resistant to complement inactivation for the treatment of cancer
Grant 11,274,141 - Luo , et al. March 15, 2
2022-03-15
Fusion Protein Between Short Form Rod-Derived Cone Viability Factor and a Hydrophilic Peptide
App 20210162005 - LUO; Tianci ;   et al.
2021-06-03
Complement factor B analogs and their uses
Grant 11,001,822 - Chen , et al. May 11, 2
2021-05-11
Fusion protein between short form rod-derived cone viability factor and a hydrophilic peptide
Grant 10,946,063 - Luo , et al. March 16, 2
2021-03-16
Complement Factor B Analogs and Their Uses
App 20200325464 - CHEN; ChangHung ;   et al.
2020-10-15
Complement factor B analogs and their uses
Grant 10,689,637 - Chen , et al.
2020-06-23
Complement Factor B Analogs and Their Uses
App 20190338268 - CHEN; ChangHung ;   et al.
2019-11-07
Complement factor B analogs and their uses
Grant 10,415,026 - Chen , et al. Sept
2019-09-17
Enveloped Virus Resistant to Complement Inactivation for the Treatment of Cancer
App 20190194292 - LUO; Tianci ;   et al.
2019-06-27
Fusion Protein Between Short Form Rod-Derived Cone Viability Factor and a Hydrophilic Peptide
App 20190151410 - LUO; Tianci ;   et al.
2019-05-23
Vectors encoding rod-derived cone viability factor
Grant 10,040,835 - Luo August 7, 2
2018-08-07
Complement Factor B Analogs and Their Uses
App 20170037391 - CHEN; ChangHung ;   et al.
2017-02-09
Complement factor B analogs and their uses
Grant 9,533,028 - Chen , et al. January 3, 2
2017-01-03
Vectors Encoding Rod-derived Cone Viability Factor
App 20160108099 - LUO; Tianci
2016-04-21
Complement Factor B Analogs And Their Uses
App 20160082091 - CHEN; ChangHung ;   et al.
2016-03-24
Vectors encoding rod-derived cone viability factor
Grant 9,265,813 - Luo February 23, 2
2016-02-23
Method for treating ocular neovascularization
Grant 9,238,057 - Brazzell , et al. January 19, 2
2016-01-19
Complement factor B analogs and their uses
Grant 9,228,003 - Chen , et al. January 5, 2
2016-01-05
Vectors Encoding Rod-derived Cone Viability Factor
App 20140328821 - Luo; Tianci
2014-11-06
Complement Factor B Analogs And Their Uses
App 20140249072 - Chen; ChangHung ;   et al.
2014-09-04
Method for Treating Ocular Neovascularization
App 20130165503 - BRAZZELL; Romulus Kimbro ;   et al.
2013-06-27
Method for treating ocular neovascularization
Grant 8,338,384 - Brazzell , et al. December 25, 2
2012-12-25
Bovine immunodeficiency virus (BIV) based vectors
Grant 8,236,558 - Luo , et al. August 7, 2
2012-08-07
Lentiviral packaging constructs
Grant 8,183,356 - Kaleko , et al. May 22, 2
2012-05-22
Bovine Immunodeficiency Virus (BIV) Based Vectors
App 20110171733 - Luo; Tianci ;   et al.
2011-07-14
Method for treating ocular neovascularization
App 20100286253 - Brazzell; Romulus Kimbro ;   et al.
2010-11-11
Bovine immunodeficiency virus (BIV) based vectors
Grant 7,785,877 - Luo , et al. August 31, 2
2010-08-31
Treatment Of Diseases Characterized By Inflammation
App 20100120665 - Kaleko; Michael ;   et al.
2010-05-13
Lentiviral packaging constructs
Grant 7,700,342 - Kaleko , et al. April 20, 2
2010-04-20
Bovine immunodeficiency virus (BIV) based vectors
Grant 7,662,621 - Luo , et al. February 16, 2
2010-02-16
Bovine immunodeficiency virus (BIV) based vectors
App 20090093040 - Luo; Tianci ;   et al.
2009-04-09
Lentiviral Packaging Constructs
App 20080268522 - Kaleko; Michael ;   et al.
2008-10-30
Lentiviral packaging constructs
Grant 7,442,551 - Kaleko , et al. October 28, 2
2008-10-28
Lentiviral Packaging Constructs
App 20080021207 - Kaleko; Michael ;   et al.
2008-01-24
Bovine Immunodeficiency Virus (biv) Based Vectors
App 20070207546 - Luo; Tianci ;   et al.
2007-09-06
Bovine immunodeficiency virus (BIV) based vectors
Grant 7,202,079 - Luo , et al. April 10, 2
2007-04-10
Bovine immunodeficiency virus (BIV) based vectors
Grant 7,198,793 - Luo , et al. April 3, 2
2007-04-03
Lentiviral Packaging Constructs
App 20070010017 - Kaleko; Michael ;   et al.
2007-01-11
Bovine immunodeficiency virus (BIV) based vectors
Grant 7,153,512 - Luo , et al. December 26, 2
2006-12-26
Bovine immunodeficiency virus (BIV) based vectors
Grant 7,125,712 - Luo , et al. October 24, 2
2006-10-24
Lentiviral packaging constructs
Grant 7,070,993 - Kaleko , et al. July 4, 2
2006-07-04
Bovine immunodeficiency virus (BIV) based vectors
App 20060019394 - Luo; Tianci ;   et al.
2006-01-26
Bovine immunodeficiency virus (BIV) based vectors
App 20050208660 - Luo, Tianci ;   et al.
2005-09-22
Recombinant bovine immunodeficiency virus based gene transfer system
App 20050191747 - Luo, Tianci ;   et al.
2005-09-01
Bovine immunodeficiency virus (BIV) based vectors
App 20050148078 - Luo, Tianci ;   et al.
2005-07-07
Bovine immunodeficiency virus (BIV) based vectors
App 20050148077 - Luo, Tianci ;   et al.
2005-07-07
Bovine immunodeficiency virus (BIV) based vectors
Grant 6,864,085 - Luo , et al. March 8, 2
2005-03-08
Lentiviral packaging constructs
App 20030054548 - Kaleko, Michael ;   et al.
2003-03-20
Bovine immunodeficiency virus (BIV) based vectors
App 20020098475 - Luo, Tianci ;   et al.
2002-07-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed